Beginning Cash: The amount of cash reported by the company on its previous statement.
First Tracks Biotherapeutics, Inc. (TRAX) had Beginning Cash of 238.20M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
-50.48M |
|
-- |
|
-- |
|
52.81M |
|
-52.81M |
|
2.33M |
|
-50.48M |
|
-50.48M |
|
-50.48M |
|
-50.48M |
|
-50.48M |
|
-50.48M |
|
-52.81M |
|
-52.69M |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
289.40M |
|
1.17M |
|
1.17M |
|
290.58M |
|
33.11M |
|
-- |
|
-- |
|
33.11M |
|
257.46M |
|
257.46M |
|
257.46M |
|
-- |
|
| Cash Flow Statement Financials | |
-32.56M |
|
34.98M |
|
7.85M |
|
|
Beginning Cash |
238.20M |
248.47M |
|
10.27M |
|
11.50M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.74 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-32.58M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-19.61% |
|
-19.61% |
|
-17.37% |
|
-19.61% |
|
-- |
|
-- |
|
-- |
|